I-Asparaginase erwinia chrysanthemi, Imithi yeJazz, I-JZP458-201, I-NCT04145531, I-Rylaze

I-FDA ivume i-asparaginase erwinia chrysanthemi (ephindayo) ye-leukemia ne-lymphoma

Agasti 2021: I-Food and Drug Administration igunyaze i-asparaginase erwinia chrysanthemi (i-recombinant)-rywn) (i-Rylaze, i-Jazz Pharmaceuticals, Inc.) njengengxenye yohlobo lwemithi ye-chemotherapeutic enama-agent amaningi yokwelashwa kwe-acute lym.

I-Avapritinib, I-Ayvakit ™, I-Blueprint Medicines Corp, ISIVIVINYO, isimila se-hematological, I-NCT02561988, I-NCT03580655, IPATHFINDER

I-Avapritinib ivunyelwe yi-FDA nge-advanced systemic mastocytosis

Agasti 2021: I-FDA ivume i-avapritinib (i-Ayvakit TM, iBlueprint Medicines Corp.) yeziguli ezindala ezine-advanced systemic mastocytosis (AdvSM), efaka nolaka lwe-systemic mastocytosis (ASM), systemic mastocytosis nge ..

I-BMS, Breyanzi, Ukwelashwa kwe-CAR - T Cell, ISIMOTO SEMOTO, Ukwelashwa kwenqola, USFDA

IBreyanzi - Ukwelashwa okusha kwe-CAR T-Cell kusuka ku-BMS

Julayi 2021: I-Breyanzi (Lisocabtagene maraleucel; liso-cel), i-CD19-directed chimeric antigen receptor (CAR) T cell treatment eyakhiwe nguBristol Myers Squibb (BMS), ivunywe yi-US Food and Drug Administration (US.).

Izinketho zokwelashwa kwe-leukemia

Ngoba ukwahlukaniswa kwe-leukemia kanye ne-prognosis stratification kuyinkimbinkimbi, ayikho indlela yokwelapha esayizi eyodwa, futhi kuyadingeka ukuhlanganisa ukuhlukaniswa ngokucophelela kanye ne-prognosis stratification ukwenza ukwelashwa p ..

Indaba yokwelashwa kwesikhungo somdlavuza i-MD Anderson yesiguli se-leukemia

U-Eddle noPearlie Saddler, njengoba umkakhe uPearlie ethemba, "bajabulela impilo ejwayelekile" edolobheni labo laseNingizimu Carolina. Lapho bephumule, abakwaSaddlers bavolontiya futhi babamba iqhaza enkonzweni esontweni. "Siya lapho kaningi, ikakhulukazi u-Eddi ..

Ucwaningo luthola imibono emisha yokwelashwa kwe-leukemia

Ucwaningo olusha lwaseMcMaster University eCanada luthi seluthole isu elisha lokwelashwa kwe-acute myeloid leukemia. Ngokuvuselela ukukhiqizwa kwamaseli anonile emnkantsheni wethambo nokulungisa umongo wethambo i-microenvir ..

Isidakamizwa esibhekiswe ku-AstraZeneca i-Acalabrutinib inendlela entsha yokwelapha i-leukemia engapheli ye-lymphocytic

I-Acalabrutinib iyi-inhibitor yesizukulwane sesibili i-tyrosine kinase (BTK) inhibitor, umuthi omusha ongathuthukisa ukusinda kwe-lymphocytic leukemia (CLL) ne-mantle cell lymphoma (MCL) .Abaphenyi bakholelwa ukuthi i-BTK inhibitors comb ..

Umhlahlandlela wokwelashwa kwe-phenotype leukemia acute

Ucwaningo olwenziwe eLos Angeles Children's Hospital luhlinzeka ngemithi engcono kakhulu yokwelapha i-leukemia engajwayelekile ebizwa ngokuthi i-mixed phenotype acute leukemia (MPAL). Lolu cwaningo (oluyiminyaka engama-20 lokuhlanganiswa kobungako besayensi l ..

Lesi sidakamizwa se-anticancer sisazuza ngemuva kweminyaka emihlanu yokwelashwa kwe-leukemia

Ngokwemiphumela yokulandelwa kweminyaka emihlanu kwecala elibalulekile le-PACE elishicilelwe kuJenaliology ye-Hematology, i-panatinib (Ponatinib, Iclusig) igcine isiguli esihlala isikhathi eside ezigulini ezelapheke kakhulu ezine-chronic phase chronic myeloi ..

Izidakamizwa ze-lymphoma leukemia ukwelapha izicubu zobuchopho

Ucwaningo olusha lweCleveland Clinic lubonisa okokuqala ukuthi ibrutinib (ibrutinib) evunyelwe yi-FDA ye-lymphoma ne-leukemia nayo ingasiza ekwelapheni izicubu zobuchopho ezivame kakhulu nezibulalayo, futhi kungasetshenziswa usuku olulodwa ezigulini ezine-gliobla ..